Table 1. GSEA pathways significantly enriched in MM patients with high or low Cdc20 expression.

	Size	Es	Nes	p-value
GSEA pathways significantly enriched in MM patients with high Cdc20 expression
pujana_chek2_pcc_network	414	−0.68	−2.66	< 0.0001
zheng_glioblastoma_plasticity_up	207	−0.69	−2.65	< 0.0001
shedden_lung_cancer_poor_survival_a6	319	−0.78	−2.62	< 0.0001
pujana_brca2_pcc_network	280	−0.75	−2.62	< 0.0001
tarte_plasma_cell_vs_plasmablast_dn	194	−0.77	−2.61	< 0.0001
wong_embryonic_stem_cell_core	190	−0.77	−2.60	< 0.0001
reactome_cell_cycle	251	−0.72	−2.58	< 0.0001
vecchi_gastric_cancer_early_up	313	−0.73	−2.58	< 0.0001
patil_liver_cancer	473	−0.61	−2.58	< 0.0001
lindgren_bladder_cancer_cluster_3_up	218	−0.75	−2.58	< 0.0001
GSEA pathways significantly enriched in MM patients with low Cdc20 expression
reactome_inhibition_of_voltage_gated_ca2_channels_via_gbeta_gamma_subunits	21	0.63	1.85	< 0.0001
zhan_multiple_myeloma_pr_dn	32	0.62	1.81	0.023
vilimas_notch1_targets_up	47	0.49	1.75	0.004
reactome_inwardly_rectifying_k_channels	26	0.58	1.73	0.004
biocarta_cardiacegf_pathway	15	0.62	1.73	0.008
sumi_hnf4a_targets	27	0.54	1.72	0.013
kondo_prostate_cancer_with_h3k27me3	129	0.45	1.70	0.002
meissner_brain_hcp_with_h3_unmethylated	29	0.56	1.69	0.008
reactome_nuclear_receptor_transcription_pathway	37	0.50	1.69	0.012